eFFECTOR Therapeutics is Drug Discovery in United States that focus on eFFECTOR Therapeutics Inc business. Founded in 2012. They cover business area such as eFFECTOR Therapeutics Inc, oncology drug, selective translation regulator inhibitor, STRIs, its product candidate, its activate kinase, mitogen-activate protein, MNK, pathway, cancer, frequent culprit, key disease-drive process.
2012
( 12 years old in 2024 )
EFFECTOR Therapeutics Inc
-
11120 Roselle Street
Suite A
San Diego, CA 92121
United States
Private
eFFECTOR Therapeutics Inconcology drugselective translation regulator inhibitorSTRIsits product candidateits activate kinasemitogen-activate proteinMNKpathwaycancerfrequent culpritkey disease-drive process
* We use standard office opening hours in near eFFECTOR Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
EFFECTOR Therapeutics is Drug Discovery business from United States that founded in 2012 (12 years old in 2024), eFFECTOR Therapeutics business is focusing on EFFECTOR Therapeutics Inc.
eFFECTOR Therapeutics headquarter office and corporate office address is located in 11120 Roselle Street Suite A San Diego, CA 92121 United States.
eFFECTOR Therapeutics was founded in United States.
In 2024, eFFECTOR Therapeutics is currently focus on eFFECTOR Therapeutics Inc sector.
Above is snippet of Google Trends for "eFFECTOR Therapeutics Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with eFFECTOR Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
